Pliant Therapeutics (PLRX) Non-Current Debt (2022 - 2025)
Pliant Therapeutics (PLRX) posted quarterly Non-Current Debt of $30.4 million for Q3 2025, up 1.0% year-over-year from $30.1 million in Q3 2024, and little changed quarter-over-quarter from $30.4 million in Q2 2025.
Pliant Therapeutics (PLRX) Non-Current Debt (2022 - 2025) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Non-Current Debt for 4 consecutive years, with $30.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Non-Current Debt rose 1.0% year-over-year to $30.4 million; the TTM figure through Sep 2025 stood at $30.4 million (up 1.0% YoY), while the FY2024 annual figure was $30.2 million, up 200.49% from the prior year.
- Non-Current Debt held at $30.4 million in Q3 2025 per PLRX's latest filing, from $30.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $30.4 million in Q3 2025 and bottomed at $9.9 million in Q2 2022.
- Historically, Non-Current Debt has averaged $20.1 million across 4 years, with a median of $20.0 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Debt jumped 201.29% — and 2025, when it advanced 0.94%.
- Pliant Therapeutics' Non-Current Debt stood at $9.9 million in 2022, then climbed by 1.26% to $10.1 million in 2023, then surged by 200.49% to $30.2 million in 2024, then increased by 0.75% to $30.4 million in 2025.
- Business Quant data shows PLRX's Non-Current Debt at $30.4 million in Q3 2025, $30.4 million in Q2 2025, and $30.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30.44 Mn |
| Jun 30, 2025 | 30.36 Mn |
| Mar 31, 2025 | 30.28 Mn |
| Dec 31, 2024 | 30.21 Mn |
| Sep 30, 2024 | 30.14 Mn |
| Jun 30, 2024 | 30.07 Mn |
| Mar 31, 2024 | 30.00 Mn |
| Dec 31, 2023 | 10.05 Mn |
| Sep 30, 2023 | 10.02 Mn |
| Jun 30, 2023 | 9.99 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 9.93 Mn |
| Sep 30, 2022 | 9.90 Mn |
| Jun 30, 2022 | 9.87 Mn |